triazoles has been researched along with Dermatitis Medicamentosa in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Usayaporn, S; Vanichanan, J; Weeraphon, B | 1 |
| Kumano, Y; Nagai, A; Sugiura, K | 1 |
| Belli, AA; Dere, Y; Karakus, V; Polat, AK | 1 |
| Adjei, AA; Bishop, WR; Carr, D; Chun, P; Cooper, A; Dayananth, P; Deng, Y; Flaherty, KT; Fong, PC; Hwu, WJ; Kirschmeier, P; Long, BJ; Miselis, NR; Moreno, BH; Moschos, SJ; Ramanathan, RK; Ribas, A; Robert, L; Rubin, EH; Rubino, J; Rush, TS; Samatar, AA; Schiller, J; Shapira-Frommer, R; Shipps, GW; Sullivan, RJ; Tawbi, HA; Zhang, D | 1 |
| Alimena, G; Breccia, M | 1 |
| Katoh, N; Konishi, K; Nakai, N; Ohshita, A | 1 |
| Abdollah Gorji, F; Alavi, S; Arzanian, MT; Ebadi, M; Ghazizadeh, F; Shamsian, B | 1 |
| Barbosa, NS; Wetter, DA | 1 |
| Bock, VL; Friedlander, M; Kossard, S; Waring, D; Wood, GK | 1 |
| Katoh, N; Nakai, N | 1 |
| Attri, SV; Bansal, D; Bhatia, P; Marwaha, RK; Totadri, S; Trehan, A | 1 |
| Avenel-Audran, M; Cellier, P; Georgin-Mège, M; Le Corre, Y; Marchand, A; Martin, L | 1 |
| Bremec, T; Demsar, J; Luzar, B; Pavlović, MD | 1 |
| Alffenaar, JW; de Monchy, JG; Kosterink, JG; Uges, DR; van Assen, S; van der Werf, TS | 1 |
| Balocco, M; Carrara, P; Forni, GL; Pinto, V | 1 |
| Höger, PH; Ott, H; Schrum, J; Vöhringer, S | 1 |
| Appenzeller, M; Bigliardi, P; Buclin, T; Grouzmann, E; Pannatier, A | 1 |
| Ogawa, Y; Shimada, S; Tanaka, K | 1 |
| Schmutz, JL; Trechot, P | 1 |
| Caminal-Montero, L; Coto-Segura, P; Esteve-Martinez, A; Mas-Vidal, A; Santos-Juanes, J | 1 |
| Alimena, G; Breccia, M; Colafigli, G; Federico, V; Finsinger, P; Latagliata, R; Loglisci, G; Petrucci, L; Salaroli, A; Santopietro, M; Serrao, A | 1 |
| Denning, DW; Felton, S; Haylett, AK; Rhodes, LE | 1 |
| Cowen, EW; Elbaum, DJ | 1 |
| Moore, KA; Potter, JE | 1 |
| Baier, M; Gattermann, N; Giagounidis, A; Haase, D; Höchsmann, B; Hofmann, WK; Junkes, A; Leismann, O; Lübbert, M; Lück, A; Nolte, F; Platzbecker, U; Schrezenmeier, H; Schumann, C; Taupitz, M | 1 |
| Blazes, DL; Dolan, CK; Hall, MA; Norwood, CW | 1 |
| Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N | 1 |
| Corbett, JR; McKeown, PP; Tolland, JP | 1 |
| Vichinsky, E | 1 |
5 review(s) available for triazoles and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Efficacy and safety of deferasirox in myelodysplastic syndromes.
Topics: Benzoates; Chelation Therapy; Clinical Trials, Phase II as Topic; Deferasirox; Drug Eruptions; Drug Therapy, Combination; Ferritins; Gastrointestinal Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Multicenter Studies as Topic; Myelodysplastic Syndromes; NF-kappa B; Oxidative Stress; Prospective Studies; Retrospective Studies; Survival Analysis; Transfusion Reaction; Triazoles | 2013 |
Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, Adjuvant; Drug Eruptions; Female; Humans; Nitriles; Triazoles; Urticaria; Vasculitis | 2014 |
Maculopapular-type drug eruption caused by sitagliptin phosphate hydrate: a case report and mini-review of the published work.
Topics: Aged; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drug Eruptions; Female; Humans; Hypersensitivity, Delayed; Hypoglycemic Agents; Immunologic Tests; Lymphocyte Activation; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Skin; Triazoles; Withholding Treatment | 2014 |
Severe phototoxicity associated with long-term voriconazole treatment.
Topics: Antifungal Agents; Child; Dermatitis, Photoallergic; Diagnosis, Differential; Drug Eruptions; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Clinical application of deferasirox: practical patient management.
Topics: Administration, Oral; Adult; Benzoates; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Contraindications; Creatinine; Deferasirox; Disease Management; Drug Eruptions; Gastrointestinal Diseases; Hematologic Diseases; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Transfusion Reaction; Triazoles | 2008 |
4 trial(s) available for triazoles and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
Topics: Administration, Oral; Adult; Animals; Biological Availability; Cell Line, Tumor; Diarrhea; Dogs; Dose-Response Relationship, Drug; Drug Eruptions; Drug Evaluation, Preclinical; Fatigue; Female; Humans; Indazoles; Male; MAP Kinase Signaling System; Maximum Tolerated Dose; Mice; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nausea; Neoplasm Staging; Neoplasms; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; Rats; Triazoles; Xenograft Model Antitumor Assays; Young Adult | 2018 |
Efficacy and safety of deferasirox in β-thalassemia major patients in Iran: a prospective study from a single referral center in Iran.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Deferasirox; Drug Eruptions; Female; Ferritins; Gastrointestinal Diseases; Humans; Iran; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Myocardium; Prospective Studies; Stroke Volume; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult | 2014 |
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Topics: Capsaicin; Carbonated Beverages; Cross-Over Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Edema; Erythema; Humans; Injections, Intradermal; Male; Pain; Pyrazines; Sitagliptin Phosphate; Skin; Substance P; Triazoles; Vasodilation | 2011 |
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzoates; Chelation Therapy; Creatinine; Deferasirox; Drug Eruptions; Female; Ferritins; Gastrointestinal Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Myelodysplastic Syndromes; Risk; Transfusion Reaction; Treatment Outcome; Triazoles | 2013 |
20 other study(ies) available for triazoles and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole | 2020 |
Erythro-papular type drug eruption caused by fosravuconazole L-lysine ethanolate.
Topics: Aged; Drug Eruptions; Humans; Male; Triazoles | 2021 |
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome.
Topics: Aged; Benzoates; Biopsy; Deferasirox; Drug Eruptions; Female; Humans; Iron Chelating Agents; Myelodysplastic Syndromes; Triazoles; Urticaria; Vasculitis | 2017 |
A maculopapular-type eruption associated with deferasirox administration.
Topics: Aged; Benzoates; Deferasirox; Drug Eruptions; Female; Humans; Iron Chelating Agents; Skin Diseases, Papulosquamous; Triazoles | 2013 |
Bullous phototoxicity from voriconazole.
Topics: Adult; Antifungal Agents; Dermatitis, Phototoxic; Drug Eruptions; Female; Foot Dermatoses; Humans; Pyrimidines; Skin Diseases, Vesiculobullous; Sunbathing; Triazoles; Voriconazole | 2014 |
The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Deferasirox; Deferiprone; Drug Eruptions; Drug Therapy, Combination; Female; Ferritins; Gastrointestinal Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Joint Diseases; Male; Prospective Studies; Proteinuria; Pyridones; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult | 2015 |
Exemestane-induced radiation recall dermatitis and morbilliform rash.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Arthralgia; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Eruptions; Eosinophilia; Epidermis; Exanthema; Female; Humans; Nitriles; Radiodermatitis; Radiotherapy, Adjuvant; Triazoles; Withholding Treatment | 2016 |
Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Diagnostic Errors; Drug Eruptions; Female; Humans; Mastectomy, Segmental; Nitriles; Postoperative Complications; Pruritus; Radiotherapy, Adjuvant; Scabies; Triazoles | 2009 |
Intravenous voriconazole after toxic oral administration.
Topics: Administration, Oral; Antifungal Agents; Drug Eruptions; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2010 |
Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
Topics: Administration, Oral; Arthralgia; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Infusions, Subcutaneous; Iron Chelating Agents; Iron Overload; Pyridones; Transfusion Reaction; Triazoles; Young Adult | 2010 |
Drug eruption caused by sitagliptin, a dipeptidyl peptidase-IV inhibitor.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Middle Aged; Pruritus; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Triazoles | 2012 |
[Careful: skins cancers and voriconazole].
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Male; Melanoma; Photosensitizing Agents; Pyrimidines; Skin Aging; Skin Neoplasms; Triazoles; Voriconazole; Young Adult | 2011 |
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Extremities; Female; Humans; Middle Aged; Psoriasis; Pyrazines; Sitagliptin Phosphate; Torso; Triazoles | 2012 |
Deferasirox treatment for myelodysplastic syndromes: "real-life" efficacy and safety in a single-institution patient population.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Azacitidine; Benzoates; Chelating Agents; Deferasirox; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematinics; Humans; Iron Overload; Kidney Diseases; Lenalidomide; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Thalidomide; Treatment Outcome; Triazoles | 2012 |
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
Topics: Adult; Antibodies, Antinuclear; Antifungal Agents; Aspergillosis; Drug Eruptions; Female; Humans; Light; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2013 |
Voriconazole-associated phototoxic effects and lentigo formation in an African American man.
Topics: Antifungal Agents; Coccidioidomycosis; Dermatitis, Phototoxic; Drug Eruptions; Humans; Lentigo; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clobetasol; Drug Eruptions; Female; Glucocorticoids; Humans; Middle Aged; Nitriles; Triazoles; Vulvar Lichen Sclerosus | 2013 |
Pseudoporphyria as a result of voriconazole use: a case report.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Humans; Lung Diseases, Fungal; Male; Mycetoma; Porphyria, Acute Intermittent; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole-induced pseudoporphyria.
Topics: Antifungal Agents; Candidiasis; Drug Eruptions; Female; Humans; Middle Aged; Porphyria, Acute Intermittent; Pyrimidines; Triazoles; Voriconazole | 2007 |